• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

How each U.S. state is doing in the COVID vaccine rollout

By
Erika Fry
Erika Fry
and
Nicolas Rapp
Nicolas Rapp
Down Arrow Button Icon
By
Erika Fry
Erika Fry
and
Nicolas Rapp
Nicolas Rapp
Down Arrow Button Icon
February 17, 2021, 8:00 PM ET

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.

In a week of declining coronavirus case numbers and unusually disruptive and widespread winter storms, America’s coronavirus vaccine rollout continued apace, with the nation administering an average of 1.76 million shots per day since last Wednesday, Feb. 10.

Through Tuesday, Feb. 16, 12.2% of the U.S. population, or 40.3 million people, had received at least one dose of a COVID vaccine, up from 33.8 million a week ago according to data from the Centers for Disease Control. And 15.5 million individuals, or 4.7% of the population, have been fully vaccinated with two doses of either the Pfizer or Moderna vaccines. In total, the country has administered 56.3 million doses, or 77.8% of the 72.4 million distributed.

Alaska, which has received the greatest number of vaccines per capita, leads the nation in terms of the percent of residents reached with a COVID-19 vaccine, at 17.9%. All states have reached at least 10% of their populations—aside from Georgia, Rhode Island, and Utah, which have each vaccinated 9.8% of their populations with one dose.

As the most populous state, California has both received and administered the most doses of coronavirus vaccine—8.4 million and 6.3 million doses respectively. Texas, which has been contending with a crippling winter storm and mass power outages in recent days, has received the fewest doses per capita.

The U.S. rollout is likely to get a boost in coming weeks from the one-dose COVID vaccine developed by Johnson & Johnson. Though inventory is limited, the company has applied for emergency use authorization of its vaccine, which will be the subject of FDA discussions on Feb. 26.

Last night, President Joe Biden said at a CNN town hall that the nation should have supply to fully vaccinate 300 million Americans by the end of July.

SHARE OF THE POPULATION THAT RECEIVED AT LEAST ONE SHOT

State or territoryShare vaccinated
Alaska17.9%
Alabama10.1%
Arkansas11.4%
Arizona12.3%
California12.1%
Colorado12.2%
Connecticut14.3%
District of Columbia12.5%
Delaware12.2%
Florida11.6%
Georgia9.8%
Hawaii12.1%
Iowa11.7%
Idaho10.7%
Illinois12.1%
Indiana11.9%
Kansas10.2%
Kentucky11.5%
Louisiana11.4%
Massachusetts12.8%
Maryland10.7%
Maine13.0%
Michigan11.4%
Minnesota12.1%
Missouri10.4%
Mississippi10.7%
Montana12.4%
North Carolina11.7%
North Dakota13.4%
Nebraska10.4%
New Hampshire11.2%
New Jersey12.0%
New Mexico14.4%
Nevada11.1%
New York11.0%
Ohio11.3%
Oklahoma12.3%
Oregon11.6%
Pennsylvania11.3%
Puerto Rico8.7%
Rhode Island9.8%
South Carolina10.7%
South Dakota12.8%
Tennessee10.0%
Texas10.6%
Utah9.8%
Virginia12.4%
Vermont12.6%
Washington11.8%
Wisconsin12.9%
West Virginia14.0%
Wyoming12.5%
About the Authors
Erika Fry
By Erika Fry
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon
Nicolas Rapp
By Nicolas RappInformation Graphics Director
LinkedIn icon

Nicolas Rapp is the former information graphics director at Fortune.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.